Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 7 February 2006. doi:10.1136/thx.2005.048512
Thorax 2006;61:394-399
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2005.048512v1
61/5/394    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, R P
Right arrow Articles by Rees, M I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, R P
Right arrow Articles by Rees, M I

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function

R P Young1, R Hopkins2, P N Black1, C Eddy1, L Wu1, G D Gamble1, G D Mills4, J E Garrett3, T E Eaton2, M I Rees5

1 Department of Medicine, University of Auckland, Auckland, New Zealand
2 Respiratory Services, Green Lane Hospital, Auckland, New Zealand
3 Department of Respiratory Medicine, Middlemore Hospital, South Auckland, New Zealand
4 Department of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand
5 School of Medicine, University of Wales Swansea Singleton Park, Swansea, UK

Correspondence to:
Correspondence to:
Dr R Young
Department of Medicine, Auckland Hospital, Private Bag 92024, Auckland, New Zealand; roberty{at}adhb.govt.nz

Background: Chronic obstructive pulmonary disease (COPD) is predominantly the consequence of chronic smoking exposure, but its development may be influenced by genetic variants that affect lung remodelling, inflammation, and defence from oxidant stress. A study was undertaken to determine whether genetic variants within genes encoding the antioxidant enzymes superoxide dismutase (SOD) and catalase may be associated with the development of impaired lung function.

Methods: In a case-control study, the allele and genotype frequencies of functional polymorphisms from SOD1 (CuZnSOD), SOD2 (MnSOD), SOD3 (extracellular SOD), and catalase (CAT) were compared in chronic smokers with normal lung function (resistant smokers) and in those with COPD.

Results: Significantly higher frequencies of the G allele and CG/GG genotype of the 213 SOD3 polymorphism were found in resistant smokers (odds ratios (ORs) 4.3 (95% CI 1.5 to 13.3) and 4.2, 95% CI 1.4 to 13.3), Bonferroni corrected p = 0.02 and p = 0.02, respectively) than in those with COPD. There were no differences between the COPD and resistant smokers for the SOD1, SOD2, or CAT polymorphisms tested.

Conclusions: The 213Gly variant of the SOD3 gene may, through antioxidant or anti-inflammatory effects, confer a degree of resistance in some smokers to the development of COPD.


Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SNP, single nucleotide polymorphism; SOD, superoxide dismutase

Keywords: antioxidant; chronic obstructive pulmonary disease; genes; smokers; lung function




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Dahl, R. P. Bowler, K. Juul, J. D. Crapo, S. Levy, and B. G. Nordestgaard
Superoxide Dismutase 3 Polymorphism Associated with Reduced Lung Function in Two Large Populations
Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 906 - 912.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A R Bentley, P Emrani, and P A Cassano
Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review
Thorax, November 1, 2008; 63(11): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. P. Hersh, D. L. DeMeo, and E. K. Silverman
National Emphysema Treatment Trial State of the Art: Genetics of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]


Home page
HypertensionHome page
F. B. Pipkin and on behalf of The Genetics of Preeclampsia Consorti
Smoking in Moderate/Severe Preeclampsia Worsens Pregnancy Outcome, but Smoking Cessation Limits the Damage
Hypertension, April 1, 2008; 51(4): 1042 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
K. Ganguly, T. Stoeger, S. C. Wesselkamper, C. Reinhard, M. A. Sartor, M. Medvedovic, C. R. Tomlinson, I. Bolle, J. M. Mason, G. D. Leikauf, et al.
Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure
Physiol Genomics, November 14, 2007; 31(3): 410 - 421.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. C. W. Mak, S. P. Ho, W. C. Yu, K. L. Choo, C. M. Chu, W. W. Yew, W. K. Lam, M. Chan-Yeung, and on behalf of the Hong Kong Thoracic Society Chroni
Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD
Eur. Respir. J., October 1, 2007; 30(4): 684 - 690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society